COVID-19 Vaccine: Bharat Biotech’s first nasal covid vaccine gets approval for phase 2/3 trial
India’s Bharat Biotech has received the approval to conduct a phase 2/3 human clinical trial for its nasal COVID-19 vaccine, BBV154. Phase 1 trial of the vaccine has shown that…